ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
284.20
-4.08 (-1.42%)
Aug 14, 2025, 1:46 PM - Market open
ResMed Stock Forecast
Stock Price Forecast
According to 11 professional analysts, the 12-month price target for ResMed stock ranges from a low of $180 to a high of $325. The average analyst price target of $276.82 forecasts a -2.60% decrease in the stock price over the next year.
Price Target: $276.82 (-2.60%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ResMed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 3 | 4 | 4 | 4 | 6 | 6 |
Hold | 5 | 5 | 5 | 5 | 3 | 3 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 12 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Mizuho | Mizuho | Buy Maintains $270 → $290 | Buy | Maintains | $270 → $290 | +2.04% | Aug 1, 2025 |
Stifel | Stifel | Hold Maintains $240 → $270 | Hold | Maintains | $240 → $270 | -5.00% | Aug 1, 2025 |
RBC Capital | RBC Capital | Buy Maintains $294 → $300 | Buy | Maintains | $294 → $300 | +5.56% | Aug 1, 2025 |
UBS | UBS | Strong Buy Maintains $285 → $325 | Strong Buy | Maintains | $285 → $325 | +14.36% | Aug 1, 2025 |
Keybanc | Keybanc | Buy Maintains $274 → $298 | Buy | Maintains | $274 → $298 | +4.86% | Aug 1, 2025 |
Financial Forecast
Revenue This Year
5.60B
from 5.15B
Increased by 8.76%
Revenue Next Year
6.00B
from 5.60B
Increased by 7.16%
EPS This Year
10.58
from 9.51
Increased by 11.25%
EPS Next Year
11.58
from 10.58
Increased by 9.48%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|
High | 6.0B | 6.5B | 6.8B | |
Avg | 5.6B | 6.0B | 6.4B | |
Low | 5.3B | 5.6B | 6.1B |
Revenue Growth
Revenue Growth | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|
High | 16.6% | 15.5% | 13.7% | |
Avg | 8.8% | 7.2% | 7.4% | |
Low | 3.3% | 0.6% | 2.2% |
EPS Forecast
EPS | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|
High | 11.72 | 13.00 | 13.20 | |
Avg | 10.58 | 11.58 | 12.50 | |
Low | 9.80 | 10.38 | 11.94 |
EPS Growth
EPS Growth | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|
High | 23.2% | 22.9% | 14.0% | |
Avg | 11.2% | 9.5% | 7.9% | |
Low | 3.0% | -1.9% | 3.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.